Karl von Frisch

H. Autrum

DOI: https://doi.org/10.1007/BF00612005

1982-12-01

Journal of Comparative Physiology

Abstract:

What problem does this paper attempt to address?

44Sc production from enriched 47TiO2 targets with a medical cyclotron

Gaia Dellepiane,Pierluigi Casolaro,Alexander Gottstein,Isidre Mateu,Paola Scampoli,Saverio Braccini

DOI: https://doi.org/10.1016/j.apradiso.2024.111220

IF: 1.787

2024-04-01

Applied Radiation and Isotopes

Abstract:44Sc is a β+-emitter which has been extensively studied for nuclear medicine applications. Its promising decay characteristics [t1/2 = 3.97 h, E [Formula: see text] = 632 keV (94.3%), Eγ = 1157 keV (99.9%); 1499 keV (0.91%)] make it highly attractive for clinical PET imaging, offering an alternative to the widely used 68Ga [t1/2 = 67.7 min, E [Formula: see text] = 836 keV (87.7%)]. Notably, its nearly fourfold longer half-life opens avenues for applications with biomolecules having extended biological half-lives and enables the centralized distribution of 44Sc radiopharmaceuticals. An additional advantage of employing 44Sc as a diagnostic radioisotope lies in its counterpart, the β--emitter 47Sc, which is currently under investigation for targeted radiotherapy. Together, they form an ideal theranostic pair, providing a comprehensive solution for both diagnostic imaging and therapeutic applications in nuclear medicine. At the Bern medical cyclotron, a study to optimize the production of scandium radioisotopes is currently ongoing. In this context, proton irradiation of titanium targets has been investigated, exploiting the reactions 47Ti(p,α)44Sc and 50Ti(p,α)47Sc. This approach enables the production of Sc radioisotopes within a single PET medical cyclotron facility, employing identical chemical procedures for target preparation and post-irradiation processing. In this paper, we report on cross-section measurements of the 47Ti(p,α)44Sc nuclear reaction using 95.7% enriched 47TiO2 targets. On the basis of the obtained results, the production yield and purity were calculated to assess the optimal irradiation conditions. Production tests were performed to confirm these findings.

radiology, nuclear medicine & medical imaging,nuclear science & technology,chemistry, inorganic & nuclear
Target Development towards First Production of High-Molar- Activity 44gSc and 47Sc by Mass Separation at CERN-MEDICIS

Edgars Mamis,Charlotte Duchemin,Valentina Berlin,Cyril Bernerd,Mathieu Bovigny,Eric Chevallay,Bernard Crepieux,Vadim Maratovich Gadelshin,Reinhard Heinke,Ronaldo Mendez Hernandez,Jake David Johnson,Patrīcija Kalniņa,Alexandros Koliatos,Laura Lambert,Ralf Erik Rossel,Sebastian Rothe,Julien Thiboud,Felix Weber,Klaus Wendt,Rudolfs Jānis Zabolockis,Elīna Pajuste,Thierry Stora

DOI: https://doi.org/10.3390/ph17030390

IF: 4.6

2024-03-19

Pharmaceuticals

Abstract:The radionuclides 43Sc, 44g/mSc, and 47Sc can be produced cost-effectively in sufficient yield for medical research and applications by irradiating natTi and natV target materials with protons. Maximizing the production yield of the therapeutic 47Sc in the highest cross section energy range of 24–70 MeV results in the co-production of long-lived, high-γ-ray-energy 46Sc and 48Sc contaminants if one does not use enriched target materials. Mass separation can be used to obtain high molar activity and isotopically pure Sc radionuclides from natural target materials; however, suitable operational conditions to obtain relevant activity released from irradiated natTi and natV have not yet been established at CERN-MEDICIS and ISOLDE. The objective of this work was to develop target units for the production, release, and purification of Sc radionuclides by mass separation as well as to investigate target materials for the mass separation that are compatible with high-yield Sc radionuclide production in the 9–70 MeV proton energy range. In this study, the in-target production yield obtained at MEDICIS with 1.4 GeV protons is compared with the production yield that can be reached with commercially available cyclotrons. The thick-target materials were irradiated at MEDICIS and comprised of metallic natTi, natV metallic foils, and natTiC pellets. The produced radionuclides were subsequently released, ionized, and extracted from various target and ion source units and mass separated. Mono-atomic Sc laser and molecule ionization with forced-electron-beam-induced arc-discharge ion sources were investigated. Sc radionuclide production in thick natTi and natV targets at MEDICIS is equivalent to low- to medium-energy cyclotron-irradiated targets at medically relevant yields, furthermore benefiting from the mass separation possibility. A two-step laser resonance ionization scheme was used to obtain mono-atomic Sc ion beams. Sc radionuclide release from irradiated target units most effectively could be promoted by volatile scandium fluoride formation. Thus, isotopically pure 44g/mSc, 46Sc, and 47Sc were obtained as mono-atomic and molecular ScF 2+ ion beams and collected for the first time at CERN-MEDICIS. Among all the investigated target materials, natTiC is the most suitable target material for Sc mass separation as molecular halide beams, due to high possible operating temperatures and sustained release.

pharmacology & pharmacy,chemistry, medicinal
Cyclotron produced 44gSc from natural calcium

G.W. Severin,J.W. Engle,H.F. Valdovinos,T.E. Barnhart,R.J. Nickles

DOI: https://doi.org/10.1016/j.apradiso.2012.04.030

IF: 1.787

2012-08-01

Applied Radiation and Isotopes

Abstract:(44g)Sc was produced by 16MeV proton irradiation of unenriched calcium metal with radionuclidic purity greater than 95%. The thick target yield at saturation for (44g)Sc was 213 MBq/μA, dwarfing the yields of contaminants (43)Sc,(44 m)Sc, (47)Sc and (48)Sc for practical bombardment times of 1-2h. Scandium was isolated from the dissolved calcium target by filtration, and reconstituted in small volumes of dilute HCl. Reactions with the chelate 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) indicated a reactivity of 54 ± 14 Gbq/μmol at end-of-bombardment.

radiology, nuclear medicine & medical imaging,nuclear science & technology,chemistry, inorganic & nuclear
Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid (DOTA) and Its Analogues

Ioannis Ioannidis,George Lefkaritis,Savvas N. Georgiades,Ioannis Pashalidis,George J. Kontoghiorghes

DOI: https://doi.org/10.3390/ijms25115954

IF: 5.6

2024-05-30

International Journal of Molecular Sciences

Abstract:Scandium (Sc) isotopes have recently attracted significant attention in the search for new radionuclides with potential uses in personalized medicine, especially in the treatment of specific cancer patient categories. In particular, Sc-43 and Sc-44, as positron emitters with a satisfactory half-life (3.9 and 4.0 h, respectively), are ideal for cancer diagnosis via Positron Emission Tomography (PET). On the other hand, Sc-47, as an emitter of beta particles and low gamma radiation, may be used as a therapeutic radionuclide, which also allows Single-Photon Emission Computed Tomography (SPECT) imaging. As these scandium isotopes follow the same biological pathway and chemical reactivity, they appear to fit perfectly into the "theranostic pair" concept. A step-by-step description, initiating from the moment of scandium isotope production and leading up to their preclinical and clinical trial applications, is presented. Recent developments related to the nuclear reactions selected and employed to produce the radionuclides Sc-43, Sc-44, and Sc-47, the chemical processing of these isotopes and the main target recovery methods are also included. Furthermore, the radiolabeling of the leading chelator, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), and its structural analogues with scandium is also discussed and the advantages and disadvantages of scandium complexation are evaluated. Finally, a review of the preclinical studies and clinical trials involving scandium, as well as future challenges for its clinical uses and applications, are presented.

biochemistry & molecular biology,chemistry, multidisciplinary
Production of 45Ti radioisotope by proton irradiation of natural scandium

F. Ditrói,S. Takács,M. Aikawa,D. Gantumur,H. Huang,S. Goto,H. Haba,Z. Szűcs,F. Tárkányi

DOI: https://doi.org/10.1016/j.radphyschem.2024.111572

IF: 2.776

2024-05-01

Radiation Physics and Chemistry

Abstract:45Ti is a positron emitter radioisotope with weak gamma radiation. As its half-life (T1/2 = 3.08 h) is in the same range that of 18F and comparable with 43,44Sc, it is a good metallic alternative for radio-labelling of different proteins and other applications in nuclear medicine. The activation cross section and yield for possible production routes have been measured by several authors for decades, but probably because of its weak gamma-line and the different measurement techniques the results are very different and confusing. In the present work proton induced reactions are investigated to gain reliable activation cross section for the 45Ti production from naturally monoisotopic scandium. The study also resulted in production cross sections of 44g,44m,43Sc and 44Ti as side products. The results are compared with the previous literature data and with the results of the latest TENDL version.

chemistry, physical,physics, atomic, molecular & chemical,nuclear science & technology
Optimized simulations of 50Ti(p,α) and 49Ti(d,α) reactions for hospital-cyclotron production of 47Sc

F. Barbaro,L. Canton,Y. Lashko,L. Zangrando

2023-10-04

Abstract:The production of 47Sc, a promising radioisotope for targeted radionuclide therapy, by means of hospital-cyclotron reactions is investigated. Two possible routes are considered: the proton-induced reaction on enriched 50Ti targets and the deuteron-induced reaction on enriched 49Ti targets. The cross-sections of the reactions are calculated using the TALYS code with optimized parameters and compared with the available experimental data. The optimal energy ranges for the production of 47Sc are determined by taking into account the thick-target yields and the purity of the product. The results show that both reactions can provide high yields and high purity of 47Sc. The feasibility of producing 47Sc with a hospital cyclotron is demonstrated by performing realistic simulations of the irradiation for both 50Ti(p,{\alpha}) and 49Ti(d,{\alpha}) reactions.

Medical Physics,Nuclear Theory
Address of the President of the United States on Mexican Affairs

W. Wilson

DOI: https://doi.org/10.2307/2212325

IF: 2.989

1913-10-01

American Journal of International Law

Abstract:
Study of thulium-167 cyclotron production: a potential medically-relevant radionuclide

Edoardo Renaldin,Gaia Dellepiane,Saverio Braccini,Alexander Sommerhalder,Hui Zhang,Nicholas P. van der Meulen,Robert Eichler,Zeynep Talip

DOI: https://doi.org/10.3389/fchem.2023.1288588

IF: 5.5

2023-10-19

Frontiers in Chemistry

Abstract:Introduction: Targeted Radionuclide Therapy is used for the treatment of tumors in nuclear medicine, while sparing healthy tissues. Its application to cancer treatment is expanding. In particular, Auger-electron emitters potentially exhibit high efficacy in treating either small metastases or single tumor cells due to their short range in tissue. The aim of this paper is to study the feasibility of a large-scale production of thulium-167, an Auger-electron emitter radionuclide, in view of eventual systematic preclinical studies. Methods: Proton-irradiated enriched erbium-167 and erbium-168 oxides were used to measure the production cross sections of thulium-165, thulium-166, thulium-167, and thulium-168 utilizing an 18-MeV medical cyclotron equipped with a Beam Transport Line (BTL) at the Bern medical cyclotron laboratory. The comparison between the experimental and the TENDL 2021 theoretical cross-section results were in good agreement. Additional experiments were performed to assess the production yields of thulium radioisotopes in the BTL. Thulium-167 production yield was also measured irradiating five different target materials ( 167 Er 2 O 3 , 168 Er 2 O 3 , nat Tm 2 O 3 , nat Yb 2 O 3 , 171 Yb 2 O 3 ) with proton beams up to 63 MeV at the Injector II cyclotron of Paul Scherrer Institute. Results and Discussion: Our experiments showed that an 8-h irradiation of enriched ytterbium-171 oxide produced about 420 MBq of thulium-167 with a radionuclidic purity of 99.95% after 5 days of cooling time with a proton beam of about 53 MeV. Larger activities of thulium-167 can be achieved using enriched erbium-168 oxide with a 23-MeV proton beam, obtaining about 1 GBq after 8-h irradiation with a radionuclidic purity of < 99.5% 5 days post end of bombardment.

chemistry, multidisciplinary
Production of scandium-44m and scandium-44g with deuterons on calcium-44: cross section measurements and production yield calculations

C Duchemin,A Guertin,F Haddad,N Michel,V Métivier

DOI: https://doi.org/10.1088/0031-9155/60/17/6847

IF: 3.5

2015-08-24

Physics in Medicine and Biology

Abstract:HIGHLIGHTS • Production of Sc-44 m, Sc-44 g and contaminants. • Experimental values determined using the stacked-foil technique. • Thick-Target production Yield (TTY) calculations. • Comparison with the TALYS code version 1.6.Among the large number of radionuclides of medical interest, Sc-44 is promising for PET imaging. Either the ground-state Sc-44 g or the metastable-state Sc-44 m can be used for such applications, depending on the molecule used as vector. This study compares the production rates of both Sc-44 states, when protons or deuterons are used as projectiles on an enriched Calcium-44 target. This work presents the first set of data for the deuteron route. The results are compared with the TALYS code. The Thick-Target production Yields of Sc-44 m and Sc-44 g are calculated and compared with those for the proton route for three different scenarios: the production of Sc-44 g for conventional PET imaging, its production for the new 3 γ imaging technique developed at the SUBATECH laboratory and the production of a Sc-44 m/Sc-44 g in vivo generator for antibody labelling.

engineering, biomedical,radiology, nuclear medicine & medical imaging
Radiochemical isolation of 45Ti using ion chromatography

J. Strecker,T. Wachten,B. Neumaier,I. Spahn

DOI: https://doi.org/10.1007/s10967-023-09270-z

2024-01-06

Journal of Radioanalytical and Nuclear Chemistry

Abstract:45 Ti exhibits favorable decay properties for positron emission tomography (PET) imaging and can be easily produced by the bombardment of natural scandium (Sc) by protons using the 45 Sc(p,n) 45 Ti nuclear reaction. However, separation of 45 Ti from irradiated Sc targets is arduous due to the hydrolytic instability of Ti(IV) complexes, making it a significant bottleneck for routine application of this radionuclide. In the present work, we describe the development and optimization of an ion chromatographic separation method based on trapping of 45 Ti on a hydroxamate-functionalized chelating resin and subsequent elution with oxalic acid at pH = 2.8. Under optimized conditions, this method enabled 45 Ti-recovery of 61 ± 8% within 7 min. Sc contamination in scaled-up experiments was found to be only 3.0 ± 1.8 μg/mL. The resulting 45 Ti-solution was directly used for complexation with CDTA as a model chelator, affording the corresponding [ 45 Ti]Ti(cdta) complex with a radiochemical conversion of 73 ± 3%. Conclusively, this promising method could be transferred to automated synthesis modules and should enable the preparation of 45 Ti-labeled compounds for PET imaging.

chemistry, inorganic & nuclear, analytical,nuclear science & technology
What is the most common mammographic appearance of T1a and T1b invasive breast cancer?

M. Podkrajšek,J. Zgajnar,M. Hočevar

DOI: https://doi.org/10.2478/v10019-008-0018-0

2008-12-01

Abstract:What is the most common mammographic appearance of T1a and T1b invasive breast cancer? Background. Data about the mammographic appearance of breast cancer smaller than 10 mm are very limited and different authors use different mammographic criteria. The aim of this study was to determine the most common mammographic appearance of small invasive breast cancers (T1a and T1b). Patients and methods. The study group consisted of 100 women with 102 small (1-10 mm) invasive breast cancers detected on mammography at a single institution in 16 months period. The mammographic appearance of tumours was classified as: mass, mass with associated calcifications, only calcifications or others (asymmetric density and architectural distortion). Results. The most common mammographic appearance was a mass without calcifications (60/102; 59%). Additional 12/102 (11%) tumours had a mammographic appearance of a mass with associated calcifications. Only microcalcifications were detected in 12 (11 %) and asymmetric density and architectural distortion in 18 breast cancers (18 %). Most (44/60) cancers which presented mammographically as a mass had stellate margins. The proportion of castig type calcifications was higher in women under 50 years. Conclusions: The most common mammographic finding of small breast cancer is a mass with stellate margins independent of the age of patients. Calcifications with/without mass are more common in woman under 50 years.
Production of Y-86 and other radiometals for research purposes using a solution target system

Elisabeth Oehlke,Cornelia Hoehr,Xinchi Hou,Victoire Hanemaayer,Stefan Zeisler,Michael J Adam,Thomas J Ruth,Anna Celler,Ken Buckley,Francois Benard,Paul Schaffer

DOI: https://doi.org/10.1016/j.nucmedbio.2015.06.005

Abstract:Introduction: Diagnostic radiometals are typically obtained from cyclotrons by irradiating solid targets or from radioisotope generators. These methods have the advantage of high production yields, but require additional solid target handling infrastructure that is not readily available to many cyclotron facilities. Herein, we provide an overview of our results regarding the production of various positron-emitting radiometals using a liquid target system installed on a 13 MeV cyclotron at TRIUMF. Details about the production, purification and quality control of (89)Zr, (68)Ga and for the first time (86)Y are discussed. Methods: Aqueous solutions containing 1.35-1.65 g/mL of natural-abundance zinc nitrate, yttrium nitrate, and strontium nitrate were irradiated on a 13 MeV cyclotron using a standard liquid target. Different target body and foil materials were investigated for corrosion. Production yields were calculated using theoretical cross-sections from the EMPIRE code and compared with experimental results. The radioisotopes were extracted from irradiated target material using solid phase extraction methods adapted from previously reported methods, and used for radiolabelling experiments. Results: We demonstrated production quantities that are sufficient for chemical and biological studies for three separate radiometals, (89)Zr (Asat = 360 MBq/μA and yield = 3.17 MBq/μA), (86)Y (Asat = 31 MBq/μA and yield = 1.44 MBq/μA), and (68)Ga (Asat = 141 MBq/μA and yield = 64 MBq/μA) from one hour long irradiations on a typical medical cyclotron. (68)Ga yields were sufficient for potential clinical applications. In order to avoid corrosion of the target body and target foil, nitrate solutions were chosen as well as niobium as target-body material. An automatic loading system enabled up to three production runs per day. The separation efficiency ranged from 82 to 99%. Subsequently, (68)Ga and (86)Y were successfully used to radiolabel DOTA-based chelators while deferoxamine was used to coordinate (89)Zr.
Proton-induced reactions for 47Sc (and 46Sc) production: new nuclear cross section measurements on enriched titanium targets

DOI: https://doi.org/10.1007/s10967-024-09378-w

2024-04-19

Journal of Radioanalytical and Nuclear Chemistry

Abstract:47 Sc is a theranostic radionuclide under the spotlight of the scientific community thanks to its potential for SPECT imaging and therapeutic applications. This work presents the recent measurements of proton-induced nuclear reaction cross-sections aimed at 47 Sc production using enriched 48 Ti, 49 Ti and 50 Ti targets from 23 up to 70 MeV. Since the co-production of contaminant isotopes is a key issue, and 46 Sc is the main one having a longer half-life than 47 Sc, the 48/49/50 Ti(p,x) 47 Sc and 46 Sc cross sections are presented and compared with the scarce literature data and TALYS estimations.

chemistry, inorganic & nuclear, analytical,nuclear science & technology
Nonperseverative disruption of behavioral inhibition following septal lesions in rats.

J. E. Kelsey,S. P. Grossman

DOI: https://doi.org/10.1037/H0030809

1971-05-01

Journal of Comparative and Physiological Psychology

Abstract:
Improved procedures of Sc(OH)3 precipitation and UTEVA extraction for 44Sc separation

Wioletta Wojdowska,Dariusz Pawlak,Izabela Cieszykowska,Małgorzata Żółtowska,Tomasz Janiak,Tadeusz Barcikowski,Anna Stolarz,Jarosław Choiński,Józef Parus,Piotr Garnuszek,Renata Mikołajczak

DOI: https://doi.org/10.5603/NMR.a2019.0013

Abstract:Background: 44Sc is becoming attractive as a PET radionuclide due to its decay characteristics. It can be produced from 44Ca present in natural calcium with 2.08% abundance. Materials and methods: The targets were mostly prepared from natural CaCO3 or metallic calcium in the form of pellets. After irradiation they were dissolved in 3 M hydrochloric acid and 44Sc was separated from excess of calcium by precipitation of scandium hydroxide using ammonia. Alternatively, targets were dissolved in 11 M hydrochloric acid and 44Sc was separated by extraction chromatography on UTEVA resin. As the next step, in both processes 44Sc was further purified on a cation exchange resin. Initially, the separation procedures were developed with 46Sc as a tracer. Gamma spectrometry with a high purity germanium detector was used to determine the separation efficiency. Finally, the CaCO3 pellet with 99.2% enrichment in 44Ca was activated with protons via 44Ca(p,n)44Sc nuclear reaction. Results: Altogether twenty two irradiations and separations were performed. The working procedures were developed and the quality of separated 44Sc solution was confirmed by radiolabeling of DOTATATE. The chemical purity of the product was sufficient for preclinical experiments. At the end of around 1 hour proton beam irradiation of CaCO3 pellet with 99.2% enrichment in 44Ca the obtained radioactivity of 44Sc was more than 4.8 GBq. Conclusion: 44Sc can be produced inexpensively with adequate yields and radionuclidic purity via 44Ca(p,n)44Sc nuclear reaction in small cyclotrons. The recovery yield in both investigated separation methods was comparable and amounted above 90%. The obtained 44Sc was pure in terms of radionuclide and chemical purity, as shown by the results of peptide radiolabeling.
Production of pharmaceutical grade [201Tl]Thallous chloride using 30 MeV cyclotron

Sankha Chattopadhyay,Luna Barua,D G Mahesh,Shayantani Ash,Arpit Mitra,Sujata Saha Das,Samarjit Singha,Md Neyar Alam,Madhusmita,Suprakash Roy,Prosenjit Dhang,Mukesh Jain

DOI: https://doi.org/10.1016/j.apradiso.2023.111128

Abstract:Multiple patient doses of [201Tl]TlCl has been produced using electrodeposited enriched 203Tl in 30 MeV cyclotron (Cyclone-30) with 28 MeV proton energy at 50 μA beam current for 8 h. Ion Exchange Column Chromatography (IECC) and liquid-liquid extraction has been employed for semi-automated radiochemical separation and purification of produced [201Tl]TlCl. The produced [201Tl]TlCl was used in coronary artery disease (CAD) patients.
Exploring rapid chemical separations of Sc-47 produced from photonuclear reactions on natural vanadium targets

Jessica L. Meiers,Ari Foley,Caitlin Beattie,Mathew S. Snow

DOI: https://doi.org/10.1007/s10967-022-08611-8

2022-11-12

Journal of Radioanalytical and Nuclear Chemistry

Abstract:Scandium-47 ( 47 Sc) production via bremsstrahlung irradiation of natural vanadium targets offers significant advantages for producing high purity 47 Sc; this work evaluates several rapid dissolution and chemical separation techniques for recovering high purity 47 Sc from irradiated vanadium. Techniques developed are combined into a simple, gram-scale, semi-automated target processing system that enables 47 Sc recovery from irradiated vanadium targets with chemical yields as high as 93 ± 3% and 47 Sc/V separation factors of 6 ± 3 ·10 11 within 90 min total processing times. Future research into H 2 O 2 resistant separation techniques and their applicability for direct process coupling to chelation are recommended.

chemistry, inorganic & nuclear, analytical,nuclear science & technology
Development of a SnO2-based 44Ti/44Sc generator for medical applications

Christine E Schmidt,Sam Groveman,Vanessa A Sanders,Cathy S Cutler,Jennifer A Shusterman,Melissa A Deri

DOI: https://doi.org/10.1016/j.chroma.2024.465245

2024-09-13

Abstract:Towards application of 44Sc for diagnostic nuclear medicine, a 44Ti/44Sc generator based on an inorganic resin has been evaluated. Unlike other radionuclide generators used for medical applications, the long-term retention of the parent 44Ti is vital due to its long half life. Herein, tin dioxide (SnO2), a robust inorganic-based resin, has been synthesized and used as the stationary phase for a 44Ti/44Sc generator. The sorption behavior of 44Ti/44Sc was tested on SnO2 with varying acids, concentrations, and times. Preliminary batch study results showed >88 % 44Ti retention to the resin at lower acid concentrations (0.05 M HNO3 and 0.05 M HCl). A pilot generator was evaluated for a year, demonstrating 85.3 ± 2.8 % 44Sc elution yields and 0.71 ± 0.14 % 44Ti breakthrough in 5 M HNO3. Based on capacity studies, a 7.4 MBq (200 µCi) upscaled generator system was constructed for further evaluation of the SnO2 resin stability and the efficacy of the eluted 44Sc for radiolabeling. 44Sc could be regularly eluted from this generator in 5 M HNO3 with an overall average radiochemical yield 84.7 ± 9.5 %. Post-elution processing of the 44Sc with DGA-normal resin removed all 44Ti present and allowed for high 44Sc-DOTA labeling yields of 94.2 ± 0.5 %. Overall, SnO2 has been shown to be a viable material for a 44Ti/44Sc generator.
Optimised production of technetium-94m for PET imaging by proton-irradiation of phosphomolybdic acid in cyclotron liquid target

Ross Harper,Derek R. Morim,Dhyey Mehta,Veronika Rosecker,Stephen J. Archibald,Richard Southworth,Philip J. Blower,Karin A. Stephenson,Karin M. Nielsen

DOI: https://doi.org/10.1016/j.apradiso.2024.111381

IF: 1.787

2024-06-03

Applied Radiation and Isotopes

Abstract:Natural-abundance phosphomolybdic acid (H 3 (Mo 12 PO 40 ) ‧12H 2 O, 0.181-0.552 g Mo/mL) solutions were irradiated with 12.9 MeV protons on a GE PETtrace cyclotron using an adapted standard liquid target. Technetium-94m ( 94m Tc) was produced through the 94 Mo(p,n) 94m Tc nuclear reaction with saturation yields of up to 53 ± 6 MBq/μA. End of bombardment activities of 161 ± 17 MBq and 157 ± 7 MBq were achieved for the 0.552 g Mo/mL solution (10 μA for 30 minutes) and 0.181 g Mo/mL solution (15 μA for 60 minutes), respectively. No visible degradation of the niobium target body and foil were seen during the irradiations of up to 15 μA for 60 minutes. The produced 94m Tc was separated from the target phosphomolybdic acid solution with >98% recovery using an aqueous biphasic extraction resin. Compared to previous reported liquid target methods for 94m Tc production, the better production yield, in-target solution stability during irradiation and 94m Tc separation recovery of phosphomolybdic acid makes it a very promising target material for routine clinical 94m Tc production at medical facilities with liquid targets already installed for 18 F production.

nuclear science & technology,radiology, nuclear medicine & medical imaging,chemistry, inorganic & nuclear
Terbium-149 production: a focus on yield and quality improvement towards preclinical application

C. Favaretto,P. V. Grundler,Z. Talip,U. Köster,K. Johnston,S. D. Busslinger,P. Sprung,C. C. Hillhouse,R. Eichler,R. Schibli,C. Müller,N. P. van der Meulen

DOI: https://doi.org/10.1038/s41598-024-53610-2

IF: 4.6

2024-02-09

Scientific Reports

Abstract:Terbium-149 (T 1/2 = 4.1 h, E α = 3.98 MeV (16.7%), 28 μm range in tissue) is a radionuclide with potential for targeted alpha therapy. Due to the negligible emission of α-emitting daughter nuclides, toxicity to healthy tissue may be reduced in comparison with other α-particle emitters. In this study, terbium-149 was produced via 1.4 GeV proton irradiation of a tantalum target at the CERN-ISOLDE facility. The spallation products were mass separated and implanted on zinc-coated foils and, later, radiochemically processed. Terbium-149 was separated from the co-produced isobaric radioisotopes and the zinc coating from the implantation foil, using cation-exchange and extraction chromatographic techniques, respectively. At the end of separation, up to 260 MBq terbium-149 were obtained with > 99% radionuclidic purity. Radiolabeling experiments were performed with DOTATATE, achieving 50 MBq/nmol apparent molar activity with radiochemical purity > 99%. The chemical purity was determined by inductively coupled plasma–mass spectrometry measurements, which showed lead, copper, iron and zinc only at ppb level. The radiolabeling of the somatostatin analogue DOTATATE with [ 149 Tb]TbCl 3 and the subsequent in vivo PET/CT scans conducted in xenografted mice, showing good tumor uptake, further demonstrated product quality and its ability to be used in a preclinical setting.

multidisciplinary sciences

Karl von Frisch

44Sc production from enriched 47TiO2 targets with a medical cyclotron

Target Development towards First Production of High-Molar- Activity 44gSc and 47Sc by Mass Separation at CERN-MEDICIS

Cyclotron produced 44gSc from natural calcium

Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid (DOTA) and Its Analogues

Production of 45Ti radioisotope by proton irradiation of natural scandium

Optimized simulations of 50Ti(p,α) and 49Ti(d,α) reactions for hospital-cyclotron production of 47Sc

Address of the President of the United States on Mexican Affairs

Study of thulium-167 cyclotron production: a potential medically-relevant radionuclide

Production of scandium-44m and scandium-44g with deuterons on calcium-44: cross section measurements and production yield calculations

Radiochemical isolation of 45Ti using ion chromatography

What is the most common mammographic appearance of T1a and T1b invasive breast cancer?

Production of Y-86 and other radiometals for research purposes using a solution target system

Proton-induced reactions for 47Sc (and 46Sc) production: new nuclear cross section measurements on enriched titanium targets

Nonperseverative disruption of behavioral inhibition following septal lesions in rats.

Improved procedures of Sc(OH)3 precipitation and UTEVA extraction for 44Sc separation

Production of pharmaceutical grade [201Tl]Thallous chloride using 30 MeV cyclotron

Exploring rapid chemical separations of Sc-47 produced from photonuclear reactions on natural vanadium targets

Development of a SnO2-based 44Ti/44Sc generator for medical applications

Optimised production of technetium-94m for PET imaging by proton-irradiation of phosphomolybdic acid in cyclotron liquid target

Terbium-149 production: a focus on yield and quality improvement towards preclinical application